Neupogen and Videx drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Neupogen (filgrastim) and Videx (didanosine). Common drug interactions include movement disorder among females and lipodystrophy acquired among males.

The phase IV clinical study analyzes what interactions people have when they take Neupogen and Videx. It is created by eHealthMe based on reports of 42 people who take the same drugs from the FDA, and is updated regularly.

What is Neupogen?

Neupogen has active ingredients of filgrastim. It is often used in agranulocytosis. eHealthMe is studying from 23,898 Neupogen users. Check the latest studies of Neupogen.

What is Videx?

Videx has active ingredients of didanosine. eHealthMe is studying from 7,927 Videx users. Check the latest studies of Videx.



On Jul, 26, 2026

42 people who take Neupogen and Videx together, and have interactions are studied.

Neupogen and Videx drug interactions.

What are the common drug interactions of Neupogen and Videx, by gender? *:

female:

  1. Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)
  2. Mucosal inflammation (infection of mucous membrane)
  3. Pain
  4. Weight decreased
  5. Abdominal discomfort
  6. Abdominal pain
  7. Alanine aminotransferase increased
  8. Anxiety
  9. B-cell lymphoma (blood cancer affecting b cells)
  10. Back pain

male:

  1. Lipodystrophy acquired (a regional loss of subcutaneous adipose tissue which usually starts in the face, extends downward acquired)
  2. Diplopia (double vision)
  3. Abdominal discomfort
  4. Abdominal pain
  5. Alanine aminotransferase increased
  6. Back pain
  7. Blood triglycerides increased
  8. Bone infarction (ischemic death of the cellular elements of the bone and marrow)
  9. Bone lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries)
  10. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)

What are the common drug interactions of Neupogen and Videx, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)
  2. Pain
  3. Pruritus (severe itching of the skin)
  4. Pyrexia (fever)
  5. Rash maculo-papular (red area on the skin that is covered with small confluent bumps)

20-29:

  1. Hypertension (high blood pressure)
  2. Anaemia (lack of blood)
  3. B-cell lymphoma (blood cancer affecting b cells)
  4. Convulsions (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled of muscles contract and relax rapidly and repeatedly)
  5. Cytomegalovirus chorioretinitis (infection of choroid and retina of the eye from virus)
  6. Encephalopathy (functioning of the brain is affected by some agent or condition)
  7. Erythroblastosis (he abnormal presence of erythroblasts in the blood)
  8. Hiv test positive
  9. Leukopenia (less number of white blood cells in blood)
  10. Megaloblasts increased (excess abnormally large nucleated red blood cell)

30-39:

  1. Renal failure acute (rapid kidney dysfunction)
  2. Blood potassium increased
  3. Blood creatinine increased
  4. Acquired immunodeficiency syndrome (disease of the human immune system caused by the human immunodeficiency virus (hiv))
  5. Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
  6. Asthenia (weakness)
  7. Disease progression
  8. Malaise (a feeling of general discomfort or uneasiness)
  9. Pancreatitis (inflammation of pancreas)
  10. Pneumonia

40-49:

  1. Jaundice cholestatic
  2. Mouth ulceration (mouth ulcers)
  3. Pancreatitis acute (sudden inflammation of pancreas)
  4. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  5. Peripheral embolism (sudden interruption of blood flow to an organ or body part)
  6. Anaemia (lack of blood)
  7. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  8. Anxiety
  9. Arthralgia (joint pain)
  10. Bone density decreased

50-59:

  1. Diarrhoea
  2. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  3. Mucosal inflammation (infection of mucous membrane)
  4. Pyrexia (fever)

60+:

n/a

What are the existing conditions these people have? *

  1. Hiv Infection: 9 people, 21.43%

* Approximation only. Some reports may have incomplete information.

Do you take Neupogen and Videx?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Neupogen and Videx:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Neupogen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Videx:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Neupogen and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Videx and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on filgrastim and didanosine (the active ingredients of Neupogen and Videx, respectively), and Neupogen and Videx (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: